See every side of every news story
Get Started
SubscribeLogin
Pope Francis
Olaf Scholz
Volodymyr Zelenskyy
Ukraine War
Vatican
German Politics
Donald Trump
Basketball
Israel-Hamas Conflict
Hamas
Wrestling
Baseball
Published • loading... • Updated

Researchers develop novel computational approach for identifying synergistic drug combinations

Summary by Science Daily
Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study highlights iDOMO's ability to identify synergistic drug combinations using gene expression data, outperforming existing methods.

3 Articles

All
Left
Center
1
Right
Science DailyScience Daily

Researchers develop novel computational approach for identifying synergistic drug combinations

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study highlights iDOMO's ability to identify synergistic drug combinations using gene expression data, outperforming existing methods.

·United States
Read Full Article
Open Access GovernmentOpen Access Government

iDOMO: New AI tool predicts synergistic drug combinations

Researchers at Mount Sinai have developed iDOMO, a powerful AI tool that predicts synergistic drug combinations for complex diseases like cancer This innovative approach leverages the power of gene expression data and artificial intelligence to predict synergistic drug pairings, potentially accelerating the development of treatments for complex diseases like cancer and offering new hope for patients who haven’t responded to traditional therapies…

Read Full Article
Medical XpressMedical Xpress

Novel computational tool for identifying synergistic drug combinations developed

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study, published in Briefings in Bioinformatics on February 20, highlights iDOMO's ability to identify synergistic drug combinations using gene expression data, outperforming existing methods.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Thursday, February 20, 2025.
Sources are mostly out of (0)

Similar News Topics

Cancer

Cancer

Tech

Tech

Artificial Intelligence

Artificial Intelligence

New York State

New York State

News
For You
Search
BlindspotLocal